Physician profile

Wilson P Smith

Critical Care Medicine (Internal Medicine) · Spartanburg, SC

NPI 1982675625

$17,179.36

in general payments reported to CMS, 2019-2025

48 companies · $3,067 in 2025

The $3,067 reported for 2025 was more than what 90% of Critical Care Medicine (Internal Medicine) providers received nationally (typical 2025 total: $189).

See the full distribution for Critical Care Medicine (Internal Medicine)

Payments by year

General payments by program year, as reported to CMS.

What the payments were for

Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.

View as a table
Payment typeAmount (2023-2025)
Food and Beverage$8,759.04
Education$30.62

Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.

Who reported paying

General payments only, as reported to CMS. Product names cover 2023-2025.

CompanyGeneral paymentsYearsTop products
Astrazeneca Pharmaceuticals LP $2,268.88 2019-2025 Fasenra, Tezspire, Airsupra
Glaxosmithkline, LLC. $2,169.40 2019-2025 Trelegy Ellipta, Arexvy, Nucala
Boehringer Ingelheim Pharmaceuticals, INC. $1,927.62 2019-2024 Ofev, Stiolto Respimat, Spiriva Respimat
Grifols USA, LLC $1,087.55 2019-2025 Prolastin-C Liquid, Xembify
Insmed, INC. $991.07 2019-2025 Arikayce, Brinsupri
Actelion Pharmaceuticals US, INC. $916.38 2019-2025 Opsumit, Uptravi
Electromed, INC. $852.21 2019-2025 Smartvest
Gilead Sciences, INC. $738.65 2021-2024 Veklury
Harmony Biosciences LLC $665.38 2020-2025 Wakix
Regeneron Healthcare Solutions, INC. $571.57 2021-2025 Dupixent
Axsome Therapeutics, INC. $537.27 2023-2025 Sunosi
Genzyme Corporation $523.42 2019-2025
Avadel Cns Pharmaceuticals, LLC $520.90 2023-2025 Lumryz
Jazz Pharmaceuticals INC. $428.58 2021-2023 Xywav
Verona Pharma, INC. $320.90 2025 Ohtuvayre
Show all 48 companies
CompanyGeneral paymentsYearsTop products
Genentech USA, INC. $295.63 2019-2023 Xolair
Mylan Specialty L.P. $255.10 2019-2023 Yupelri
Mallinckrodt Hospital Products INC. $206.46 2021-2022
Takeda Pharmaceuticals U.S.A., INC. $176.10 2020-2025 Glassia
Sunovion Pharmaceuticals INC. $141.85 2019-2021
Genentech, INC. $128.57 2021
Ani Pharmaceuticals, INC. $122.93 2023-2025 Purified Cortrophin Gel
Philips North America LLC $118.38 2019-2025 Vest Therapy Und
Teva Pharmaceuticals USA, INC. $114.21 2019-2022
Viatris Specialty LLC $104.56 2025 Yupelri
Advanced Respiratory, INC $94.34 2020-2021
Inspire Medical Systems, INC. $80.13 2023-2025 Inspire
Fisher & Paykel Healthcare INC $78.36 2019
Portola Pharmaceuticals, LLC $76.58 2019-2020
Circassia INC. $65.89 2019-2020
Inogen, INC. $64.70 2021-2023 Inogen One G5 Oxygen Concentrator - Bluetooth
United Therapeutics Corporation $64.38 2020-2025 Tyvaso
Merck Sharp & Dohme LLC $57.43 2025 Winrevair, Keytruda
Resmed Corp $56.72 2019-2023
Baxter Healthcare $53.50 2023 Hillrom - Life 2000 Ventilation System
Melinta Therapeutics, LLC $39.60 2021
Nabriva Therapeutics, Plc $39.58 2021
Vifor Pharma, INC. $37.27 2025 Zemaira
La Jolla Pharmaceutical Company $23.66 2022
Bayer Healthcare Pharmaceuticals INC. $22.96 2019
Pulmonx Corporation $21.90 2023 Chartis Catheter, Zephyr Delivery Catheter, Zephyr Endobronchial Valve
Lilly USA, LLC $21.74 2025 Zepbound
Itamar Medical INC $21.34 2025 Watchpatone
Gc Biopharma USA, INC. $18.64 2025 Alyglo
Vapotherm INC $15.65 2022
Veran Medical Technologies, INC. $14.15 2020
Pfizer INC. $13.69 2022
Mallinckrodt Enterprises LLC $13.58 2019

Drugs and devices associated with these payments

CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.

If you want to bring it up

Most clinicians are glad to talk about this. A respectful way in:

These are normal questions. A good clinician will welcome them.

Share this page

Payment summary

Wilson P Smith

$17,179.36

in general payments reported 2019-2025

Years
2019-2025
Top company
Astrazeneca Pharmaceuticals LP
Context
The $3,067 reported for 2025 was more than what 90% of Critical Care Medicine (Internal Medicine) providers received nationally (typical 2025 total: $189).

https://glasscript.com/doctor/316794/wilson-p-smith

Source: CMS Open Payments, program years 2019-2025. Payments are legal and often routine.

Keep an eye on this page

Get an email when the next June refresh changes this page. No account needed.

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.